Medical Stocks,Toyota Motor,Valuation Warning, and ValuEngine Capital

VALUATION WARNING: Overvalued stocks now make up 66.04% of our stocks assigned a valuation and 30.66% of those equities are calculated to be overvalued by 20% or more. Fifteen sectors are calculated to be overvalued.

ValuEngine Index Overview

Index
Week Open
Friday AM
Change
% Change
YTD
DJIA
19872.86
19961.22
88.36
0.44%
14.55%
NASDAQ
5425.62
5520.89
95.27
1.76%
10.25%
RUSSELL 2000
1357.99
1370.94
12.95
0.95%
20.69%
S&P 500
2251.57
2277.26
25.69
1.14%
11.42%

ValuEngine Market Overview

Summary of VE Stock Universe
Stocks Undervalued
33.96%
Stocks Overvalued
66.04%
Stocks Undervalued by 20%
14.01%
Stocks Overvalued by 20%
30.66%

ValuEngine Sector Overview

Sector
Change
MTD
YTD
Valuation
Last 12-MReturn
P/E Ratio
Oils-Energy
0.20%
2.80%
2.80%
20.91% overvalued
29.12%
26.80
Industrial Products
-0.90%
1.29%
1.29%
17.87% overvalued
25.54%
24.72
Multi-Sector Conglomerates
-0.18%
1.51%
1.51%
17.56% overvalued
15.91%
19.98
Finance
-0.47%
1.19%
1.19%
16.14% overvalued
16.19%
18.24
Aerospace
0.07%
2.44%
2.44%
14.80% overvalued
12.93%
20.78
Basic Materials
0.66%
4.03%
4.01%
13.83% overvalued
76.17%
27.92
Construction
-0.23%
1.76%
1.76%
11.77% overvalued
25.20%
21.67
Utilities
-0.13%
2.53%
2.53%
11.37% overvalued
19.43%
22.03
Business Services
-0.27%
0.84%
0.84%
10.65% overvalued
12.72%
24.46
Transportation
-0.43%
2.31%
2.31%
10.59% overvalued
12.36%
18.36
Computer and Technology
-0.48%
1.47%
2.05%
8.39% overvalued
15.04%
30.97
Auto-Tires-Trucks
-0.84%
1.73%
1.73%
7.86% overvalued
26.38%
15.03
Consumer Staples
0.11%
1.04%
1.04%
5.98% overvalued
11.88%
24.13
Consumer Discretionary
0.05%
1.53%
1.53%
5.02% overvalued
18.72%
23.84
Retail-Wholesale
-1.50%
1.33%
1.33%
3.33% overvalued
6.52%
23.13
Medical
-0.10%
3.48%
3.48%
5.90% undervalued
-7.78%
28.51

Sector Talk–Medical

  Below, we present the latest data on Medical stocks from our Professional Stock Analysis Service. Top- five lists are provided for each category.  We applied some basic liquidity criteria–share price greater than $3 and average daily volume in excess of 100k shares. 

Top-Five Medical Stocks–Short-Term Forecast Returns

Ticker
Name
Mkt Price
Valuation (%)
Last 12-M Return (%)
LNTH
LANTHEUS HLDGS
8.3
N/A
158.57%
ANIP
ANI PHARMACEUT
62.63
20.53%
40.58%
HCA
HCA HOLDINGS
76.81
-13.18%
15.61%
HMNY
HELIOS&MATHESON
3.4
N/A
108.40%
SCLN
SCICLONE PHARMA
10.8
N/A
26.32%

Top-Five Medical Stocks–Momentum

Ticker
Name
Mkt Price
Valuation (%)
Last 12-M Return (%)
CRBP
CORBUS PHARMACT
8.3
N/A
440.33%
CLCD
COLUCID PHARMA
32.95
N/A
284.48%
CTIC
CTI BIOPHARMA
4.46
117.62%
251.18%
EXEL
EXELIXIS INC
14.99
95.06%
184.71%
TSRO
TESARO INC
138.59
258.81%
181.63%

Top-Five Medical Stocks–Composite Score

Ticker
Name
Mkt Price
Valuation (%)
Last 12-M Return (%)
HCA
HCA HOLDINGS
76.81
-13.18%
15.61%
ABBV
ABBVIE INC
63.77
1.92%
11.16%
HLS
HEALTHSOUTH CP
41.5
-3.97%
19.42%
JNJ
JOHNSON & JOHNS
116.86
0.56%
15.82%
ZBH
ZIMMER BIOMET
104.95
-14.90%
0.98%

Top-Five Medical Stocks–Most Overvalued

Ticker
Name
Mkt Price
Valuation (%)
Last 12-M Return (%)
AEZS
AETERNA ZENTARS
3
300.00%
-28.74%
TSRO
TESARO INC
138.59
258.81%
181.63%
AKAO
ACHOGEN INC
14.7
254.72%
153.89%
CYH
COMMNTY HLTH SY
6.27
188.82%
-75.97%
CHRS
COHERUS BIOSC
28
164.30%
35.99%

 

Free Download for Readers

As a bonus to our Free Weekly Newsletter subscribers,
we are offering a FREE DOWNLOAD of one of our Stock Reports

Toyota Motor Corporation (TM) produces, sells, leases, and repairs passenger cars, trucks, buses, boats, airplanes and other products in Japan and most foreign countries. The Company is also involved in the businesses of real estate, civil engineering, insurance and so on.

VALUENGINE RECOMMENDATION:
ValuEngine continues its HOLD recommendation on TOYOTA MOTOR CP for 2017-01-05. Based on the information we have gathered and our resulting research, we feel that TOYOTA MOTOR CP has the probability to ROUGHLY MATCH average market performance for the next year. The company exhibits ATTRACTIVE Company Size but UNATTRACTIVE Earnings Growth Rate.

You can download a free copy of detailed report on Toyota Motor Corporation (TM) from the link below.

Read our Complete Detailed Valuation Report on Toyota (TM) HERE.

ValuEngine Forecast
Target
Price*
Expected
Return
1-Month
120.82 0.31%
3-Month
122.04 1.33%
6-Month
121.53 0.90%
1-Year
124.99 3.78%
2-Year
136.53 13.36%
3-Year
132.30 9.85%

 

Valuation & Rankings
Valuation
7.43% overvalued Valuation Rank(?)
53
1-M Forecast Return
0.31% 1-M Forecast Return Rank
75
12-M Return
-0.58% Momentum Rank(?)
32
Sharpe Ratio
0.63 Sharpe Ratio Rank(?)
83
5-Y Avg Annual Return
11.45% 5-Y Avg Annual Rtn Rank
75
Volatility
18.19% Volatility Rank(?)
75
Expected EPS Growth
-3.10% EPS Growth Rank(?)
16
Market Cap (billions)
189.43 Size Rank
100
Trailing P/E Ratio
11.31 Trailing P/E Rank(?)
90
Forward P/E Ratio
11.67 Forward P/E Ratio Rank
78
PEG Ratio
n/a PEG Ratio Rank
n/a
Price/Sales
0.77 Price/Sales Rank(?)
76
Market/Book
1.11 Market/Book Rank(?)
76
Beta
0.82 Beta Rank
51
Alpha
-0.12 Alpha Rank
27

ValuEngineCapital Money Management Services

We are pleased to announce that ValuEngine Capital has begun trading for our clients. ValuEngine Capital, a registered investment advisory firm, offers our clients investment-management services based on industry-leading ValuEngine research. ValuEngine Capital melds the cutting-edge financial theory of ValuEngine’s award-winning quantitative independent research with the best real-world Wall St. practices. ValuEngine Capital offers refined investment portfolios for investors of all risk-reward profiles.

ValuEngine Capital is offering several investment strategies to clients, including the the ValuEngine View Strategy and the ValuEngine Diversified Strategy

Professional Portfolio Management Services

ValuEngine View Strategy: The ValuEngine View Strategy is the product of a sophisticated stock valuation model that was first developed by ValuEngine’s academic research team.

  • It utilizes a three factor approach: fundamental variables such as a company’s trailing 12-month Earnings-Per-Share (EPS), the analyst consensus estimate of the company’s future 12-month EPS, and the 30-year Treasury yield are all used to create a more accurate reflection of a company’s fair value.
  • A total of eleven additional firm specific variables are also used. The ValuEngine View portfolio is constructed by integrating both our Aggressive Growth—based on the Valuation Model–and Diversified Growth—based on the Forecast Model– Portfolio Strategies.
  • The ValuEngine View Strategy  is constructed by integrating this model along with some basic rules for market capitalization and industry diversification. The portfolio has 15 stocks and is rebalanced once each month.

Strategies To Suit All Investor Types

The ValuEngine Diversified Strategy: The ValuEngine Diversified Strategy invests in a variety of asset classes in order to provide investors with stable returns and a high- dividend yield coupled with significantly lower risk than single-asset products. 

  • The ValuEngine Diversified Strategy may include ETFs focused on commodities, stock indices, REITS, bonds, emerging markets, and other suitable products.
  • By reaping the benefits of diversification, the ValuEngine Diversified Strategy seeks to remain resilient during times of market volatility.
  • The ValuEngine Diversified Strategy is designed for investors seeking management for their IRA and other retirement funds as well as those whose risk-profile is not suitable for our other strategies.

 

For more information, please contact us by email at info@ValuEngineCapital.com
or by phone at (407) 308-5686.

Or, sign up online with our easy-to-use portal HERE:

ValuEngine.com is an independent research provider, producing buy/hold/sell recommendations, target price, and valuations on over 7,000 US and Canadian equities every trading day.

 Visit www.ValuEngine.com for more information

Leave a Comment